Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia

1. Lee-Vergés, E.
2. Hanna, B.S.
3. Yazdanparast, H.
4. Rodríguez, V.
5. Rodríguez, M.L.
6. Giró, A.
7. Vidal-Crespo, A.
8. Rosich, L.
9. Amador, V.
10. Aymerich, M.
11. Villamor, N.
12. Delgado, J.
13. Lichter, P.
14. Pérez-Galán, P.
15. López-Guerra, M.
16. Campo, E.
17. Seiffert, M.
18. Colomer, D.